On Tuesday, September 30, the next meeting of the Transparency Council.
On Monday, September 29, the next meeting of the Transparency Council.
The Supreme Chamber of Physicians has asked the National Health Fund to provide a list of drugs that most often cause doctors difficulties in determining reimbursement levels. The president of the NRL, Lukasz Jankowski, stresses that the data could be crucial to the work on a modern, automated...
The Polish Society of Rheumatology has issued a position paper on expanding access to innovative treatment for rheumatic diseases in Poland as of October 1, 2025.
Główny Inspektorat Farmaceutyczny dołączył do europejskiej kampanii „Leki to nie słodycze”, która przypomina, że leki dostępne bez recepty powinny być stosowane odpowiedzialnie i zgodnie z zaleceniami.
This year's latest list of reimbursed drugs includes 50 molecules. Nearly half (22) are cancer therapies, including a large group of drugs dedicated to women, the Health Ministry said Monday.
Press conference by Deputy Health Minister Katherine Kacperyczk on the October draft list of reimbursed drugs.
On Monday, September 15, the next meeting of the Transparency Council.
It's all about hemophilia. - With regard to the periodically recurring information in the public space regarding limitations in access to hemophilia treatment, we assure that every patient with hemophilia has access to modern preventive and stabilizing treatment for his disease. The hemophilia...
On Monday, September 8, the next meeting of the Transparency Council.
Simon J. Britsch został powołany na stanowisko prezesa firmy Bayer w Polsce. Obejmuje je równolegle z pełnioną funkcją dyrektora finansowego na region Europy Wschodniej. Jego międzynarodowe doświadczenie oraz dogłębna znajomość firmy Bayer pozwalają mu skutecznie wspierać dalszy rozwój i...
The OJ of the Ministry of Health published a Notice of the Minister of Health dated August 27, 2025 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland.
More than 26,800 patients participated in commercial clinical trials conducted in Poland in 2024. In four years, Poland has risen from 11th to 9th place in the global ranking of the largest markets for commercial clinical trials. This is good news. The worse news is that for two years we have...
President Karol Nawrocki on August 25, 2025, signed a law amending the regulations on reimbursement of medicines, foodstuffs for special nutritional purposes and medical devices, as well as the Law on Health Care Services. The amendment brings Polish law in line with EU regulations on health...
Osoby przewlekle przyjmujące leki mogą przewozić je przez granice, ale muszą przestrzegać określonych zasad. Obowiązują limity ilościowe, wymóg przewożenia leków w oryginalnych opakowaniach oraz konieczność sprawdzenia przepisów kraju, do którego się udajemy. Rzecznik Praw Pacjenta przypomina...
On Monday, August 25, the next meeting of the Transparency Council.
On Monday, August 18, the next meeting of the Transparency Council.
On Monday, June 11, the next meeting of the Transparency Council.
On Tuesday, August 5, the next meeting of the Transparency Council.
On June 27, 2025, Biogen Inc. (Nasdaq: BIIB) announced new data supporting the clinical efficacy of nusinersen in a diverse population of patients suffering from spinal muscular atrophy.
On Monday, August 4, the next meeting of the Transparency Council.
Iwona Schymalla's guest is Dr. Krzysztof Dyrbuś, a cardiologist from the Silesian Center for Heart Diseases in Zabrze.
It will be the first and only molecularly targeted therapy in Europe for the treatment of diffuse glioblastoma grade II, with IDH (isocitrate dehydrogenase) gene mutations. What drug is involved?
On Monday, July 28, the next meeting of the Transparency Council.
National Drug Manufacturers appreciates the contribution of Minister Izabela Leszczyna and the entire leadership and team of the ministry to building Poland's drug security, and hopes that these activities will be continued by the new Minister Jolanta Sobieranska-Grenda.
Wednesday, July 23, is the next meeting of the Transparency Council.
On Monday, July 21, the next meeting of the Transparency Council.
In the face of growing challenges to drug availability in Europe, the Health Ministry has presented a new, expanded version of the National List of Critical Medicines. The document, which is crucial to securing the health needs of Poles, now includes 401 active substances - more than a hundred...
The Health Ministry is analyzing several hundred comments submitted during public consultations on the draft amendment to the Reimbursement Act and assumes that the draft will go to the Parliament soon after the parliamentary vacations. The changes concern, among other things, drug programs.
On Monday, July 14, the next meeting of the AOTMiT Transparency Council.
© 2023 Medexpress. All Rights Reserved
